Literature DB >> 19143964

Risk factors for developing severe clinical course in HUS patients: a national survey in Japan.

Ichiro Kamioka1, Kunihiko Yoshiya, Kenichi Satomura, Hiroshi Kaito, Teruo Fujita, Kazumoto Iijima, Koichi Nakanishi, Norishige Yoshikawa, Kandai Nozu, Masafumi Matsuo.   

Abstract

BACKGROUND: Hemolytic uremic syndrome (HUS) is characterized by acute renal failure, thrombocytopenia and hemolytic anemia. Cases accompanied by prodromal gastrointestinal tract symptoms are referred to as typical HUS. Some severe HUS patients require dialysis or develop central nervous system (CNS) disorders after the onset of HUS.
METHODS: Patients who developed typical HUS in 2001 and 2002 in Japan, 127 in all, were the study subjects. To identify the risk factors for the development of a severe clinical course, clinical and laboratory data were analyzed on logistic regression.
RESULTS: Two of the 127 patients died (1.6%): one from acute cardiac failure and the other from a CNS disorder. Thirty-five patients required dialysis (28%) and 30 had CNS symptoms (24%). Multivariate analysis indicated that the risk factors for need for dialysis were serum sodium and alanine aminotransferase (ALT) levels of </=130 mEq/L and >/=70 IU/L, respectively, at the onset of HUS and those for developing CNS disorders were dialysis and C-reactive protein (CRP) >/=5.0 mg/dL at the onset of HUS.
CONCLUSIONS: Because patients with these risk factors, such as low serum sodium, high ALT or high CRP levels, may require dialysis or develop CNS disorders, they should be treated carefully in the early stage of HUS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19143964     DOI: 10.1111/j.1442-200X.2008.02605.x

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  12 in total

1.  Clinical characteristics and long-term outcome of diarrhea-associated hemolytic uremic syndrome: a single center experience.

Authors:  Takeshi Ninchoji; Kandai Nozu; Keita Nakanishi; Tomoko Horinouchi; Junya Fujimura; Tomohiko Yamamura; Shogo Minamikawa; Shingo Ishimori; Koichi Nakanishi; Norishige Yoshikawa; Ichiro Morioka; Hiroshi Kaito; Kazumoto Iijima
Journal:  Clin Exp Nephrol       Date:  2017-01-10       Impact factor: 2.801

Review 2.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

3.  Outbreak of Shiga toxin-producing Escherichia-coli-associated hemolytic uremic syndrome in Istanbul in 2015: outcome and experience with eculizumab.

Authors:  Ayşe Ağbaş; Nilüfer Göknar; Nurver Akıncı; Zeynep Yürük Yıldırım; Mehmet Taşdemir; Meryem Benzer; İbrahim Gökçe; Cengiz Candan; Nuran Küçük; Selçuk Uzuner; Gül Özçelik; Demet Demirkol; Lale Sever; Salim Çalışkan
Journal:  Pediatr Nephrol       Date:  2018-08-29       Impact factor: 3.714

4.  Acute neurological involvement in diarrhea-associated hemolytic uremic syndrome.

Authors:  Sylvie Nathanson; Thérésa Kwon; Monique Elmaleh; Marina Charbit; Emma Allain Launay; Jérôme Harambat; Muriel Brun; Bruno Ranchin; Flavio Bandin; Sylvie Cloarec; Guylhene Bourdat-Michel; Christine Piètrement; Gérard Champion; Tim Ulinski; Georges Deschênes
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-24       Impact factor: 8.237

5.  Serum Transaminases at Presentation and Association with Acute Dialysis in Children with Hemolytic Uremic Syndrome.

Authors:  Saurabh Talathi; Margaux Barnes; Inmaculada Aban; Reed Dimmitt; David J Askenazi
Journal:  Kidney360       Date:  2020-03-19

6.  Impact of platelet transfusions in children with post-diarrheal hemolytic uremic syndrome.

Authors:  Alejandro Balestracci; Sandra Mariel Martin; Ismael Toledo; Caupolican Alvarado; Raquel Eva Wainsztein
Journal:  Pediatr Nephrol       Date:  2013-02-06       Impact factor: 3.714

Review 7.  Management of diarrhea-associated hemolytic uremic syndrome in children.

Authors:  Kazumoto Iijima; Ichiro Kamioka; Kandai Nozu
Journal:  Clin Exp Nephrol       Date:  2008-01-05       Impact factor: 2.801

8.  Angiopoietin-1 and -2 as markers for disease severity in hemolytic uremic syndrome induced by enterohemorrhagic Escherichia coli.

Authors:  Masaki Shimizu; Natsumi Inoue; Mondo Kuroda; Mao Mizuta; Naotoshi Sugimoto; Hisashi Kaneda; Kazuhide Ohta; Akihiro Yachie
Journal:  Clin Exp Nephrol       Date:  2016-03-05       Impact factor: 2.801

9.  Hyponatremia: a new predictor of mortality in patients with Shiga toxin-producing Escherichia coli hemolytic uremic syndrome.

Authors:  Laura F Alconcher; Paula A Coccia; Angela Del C Suarez; Marta L Monteverde; María Graciela Perez Y Gutiérrez; Paula M Carlopio; Mabel L Missoni; Alejandro Balestracci; Illiana Principi; Flavia B Ramírez; Patricia Estrella; Susana Micelli; Daniela C Leroy; Nahir E Quijada; Claudia Seminara; Marta I Giordano; Susana B Hidalgo Solís; Mariana Saurit; Alejandra Caminitti; Andrea Arias; Marta Rivas; Paula Risso; Miguel Liern
Journal:  Pediatr Nephrol       Date:  2018-06-30       Impact factor: 3.714

10.  Indicators of acute and persistent renal damage in adult thrombotic microangiopathy.

Authors:  Firuseh Dierkes; Nikolaos Andriopoulos; Christoph Sucker; Kathrin Kuhr; Markus Hollenbeck; Gerd R Hetzel; Volker Burst; Sven Teschner; Lars C Rump; Thomas Benzing; Bernd Grabensee; Christine E Kurschat
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.